BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21800312)

  • 1. Predicting human plasma protein binding of drugs using plasma protein interaction QSAR analysis (PPI-QSAR).
    Li H; Chen Z; Xu X; Sui X; Guo T; Liu W; Zhang J
    Biopharm Drug Dispos; 2011 Sep; 32(6):333-42. PubMed ID: 21800312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte carlo method-based QSAR modeling of penicillins binding to human serum proteins.
    Veselinović JB; Toropov AA; Toropova AP; Nikolić GM; Veselinović AM
    Arch Pharm (Weinheim); 2015 Jan; 348(1):62-7. PubMed ID: 25408278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis.
    Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ
    Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
    Dolezal R; Van Damme S; Bultinck P; Waisser K
    Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
    Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
    J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based in silico model profiles the binding constant of poorly soluble drugs with β-cyclodextrin.
    Li H; Sun J; Wang Y; Sui X; Sun L; Zhang J; He Z
    Eur J Pharm Sci; 2011 Jan; 42(1-2):55-64. PubMed ID: 20979986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH; Shen MY; Esposito EX; Hopfinger AJ; Tseng YJ
    J Chem Inf Model; 2010 Jul; 50(7):1304-18. PubMed ID: 20565102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting MDCK cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.
    Chen LL; Yao J; Yang JB; Yang J
    Acta Pharmacol Sin; 2005 Nov; 26(11):1322-33. PubMed ID: 16225754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
    AbdulHameed MD; Hamza A; Liu J; Zhan CG
    J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prediction models for blood brain barrier permeability and analysis of the molecular descriptors.
    Wu ZY; Pan J; Yuan Y; Hui AL; Yang Y; Zhou A
    Pharmazie; 2012 Jul; 67(7):628-34. PubMed ID: 22888521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR models for the prediction of binding affinities to human serum albumin using the heuristic method and a support vector machine.
    Xue CX; Zhang RS; Liu HX; Yao XJ; Liu MC; Hu ZD; Fan BT
    J Chem Inf Comput Sci; 2004; 44(5):1693-700. PubMed ID: 15446828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined 3D-QSAR modeling and molecular docking study on quinoline derivatives as inhibitors of P-selectin.
    Zeng H; Cao R; Zhang H
    Chem Biol Drug Des; 2009 Dec; 74(6):596-610. PubMed ID: 19843078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A structure-based QSAR and docking study on imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4,]benzodiazepines as Selective GABA(A) α5 inverse agonists.
    Gharaghani S; Khayamian T; Keshavarz F
    Chem Biol Drug Des; 2011 Oct; 78(4):612-21. PubMed ID: 21756285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
    Wei HY; Tsai KC; Lin TH
    J Chem Inf Model; 2005; 45(5):1343-51. PubMed ID: 16180911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of molecular docking as descriptors to predict human serum albumin binding affinity.
    Chen L; Chen X
    J Mol Graph Model; 2012 Mar; 33():35-43. PubMed ID: 22153983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.
    Nargotra A; Sharma S; Koul JL; Sangwan PL; Khan IA; Kumar A; Taneja SC; Koul S
    Eur J Med Chem; 2009 Oct; 44(10):4128-35. PubMed ID: 19523722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.